FTH · Forms 3, 4, 5
Insider trades at Faeth Therapeutics, Inc.
No open-market insider buys or sells at Faeth Therapeutics, Inc. in the last 90 days; 5 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Faeth Therapeutics, Inc. (FTH) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Karen H Vousden | Director | Options or other derivatives | Form 4 | ||||
| Karen H Vousden | Director | Became an insider (Form 3) | Form 3 | ||||
| Khosla Ventures VI, L.P. | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Josiah Craver | PAO | Options or other derivatives | Form 4 | ||||
| Anand Kiran Parikh | President and CEO | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.